SpikoGen Covid-19 Vaccine(Cinnagen)

N/A

Report date: 2022/09/19 10:12:59

Base Information

Drug NameSpikoGen Covid-19 Vaccine(Cinnagen)
Drug Alias NameCOVAX 19Advax-CpG55.2 adjuvanted recombinant spike protein(Vaxine)Adjuvanted COVID-2019 vaccine(Vaxine)
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaIran
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCinnagen
China Registration ClassN/A

Develop Information

Active CompaniesVaxine Pty LtdCinnagen
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A